Hoth Therapeutics, Inc. — Director's Dealing 2019

Dec 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-12-24

Reporting Person: Knie Robb (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-24	Options	$5.26	J	250000	Acquired	2029-12-24	Common Stock (250000)	Direct

Footnotes

F1: The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.